|
1
|
Bosnic-Anticevich SZ, Cvetkovski B, Azzi EA, Srour P, Tan R, Kritikos V. Identifying Critical Errors: Addressing Inhaler Technique in the Context of Asthma Management. Pulm Ther 2018; 4:1-12. [PMID: 32026244 PMCID: PMC6966926 DOI: 10.1007/s41030-018-0051-0] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2018] [Indexed: 12/24/2022] Open
Abstract
Medication use has always played a highly significant role in the overall management of asthma, with appropriate use being linked to good asthma control. However, while patients with asthma enjoy the 'luxury' of having medications delivered directly to the lungs via inhaler devices, with that comes the additional challenge of ensuring that inhaler devices are used correctly. Research and practice provides evidence to the challenges associated with inhaler use and the particular steps that patients perform incorrectly. While this problem is well documented, acknowledged and reported, little has changed in 40 years, and the proportion of patients using inhaler devices remains unacceptably high. This review focuses on aspects specific to the errors that patient's make, the significance of these errors, and the important considerations for health care practitioners in supporting patients in correctly using their inhalers. This review highlights the complexities associated with patient's making inhaler technique errors and highlights the opportunities that lie in future technological developments of inhaler devices. Now more than ever, in the era of precision medicine, it is important that we address inhaler technique use once and for all.
Collapse
Affiliation(s)
- Sinthia Z Bosnic-Anticevich
- Quality Use of Respiratory Medicines Group, Woolcock Institute, Sydney Medical School, University of Sydney, Sydney, Australia.
- Woolcock Emphysema Centre, University of Sydney, Sydney, Australia.
- Sydney Local Health District, Sydney, Australia.
| | - Biljana Cvetkovski
- Quality Use of Respiratory Medicines Group, Woolcock Institute, Sydney Medical School, University of Sydney, Sydney, Australia
| | - Elizabeth A Azzi
- Quality Use of Respiratory Medicines Group, Woolcock Institute, Sydney Medical School, University of Sydney, Sydney, Australia
| | - Pamela Srour
- Quality Use of Respiratory Medicines Group, Woolcock Institute, Sydney Medical School, University of Sydney, Sydney, Australia
| | - Rachel Tan
- Quality Use of Respiratory Medicines Group, Woolcock Institute, Sydney Medical School, University of Sydney, Sydney, Australia
| | - Vicky Kritikos
- Quality Use of Respiratory Medicines Group, Woolcock Institute, Sydney Medical School, University of Sydney, Sydney, Australia
- Department of Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, Australia
| |
Collapse
|
|
2
|
Dabisch PA, Xu Z, Boydston JA, Solomon J, Bohannon JK, Yeager JJ, Taylor JR, Reeder RJ, Sayre P, Seidel J, Mollura DJ, Hevey MC, Jahrling PB, Lackemeyer MG. Quantification of regional aerosol deposition patterns as a function of aerodynamic particle size in rhesus macaques using PET/CT imaging. Inhal Toxicol 2017; 29:506-515. [DOI: 10.1080/08958378.2017.1409848] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Affiliation(s)
- P. A. Dabisch
- Battelle National Biodefense Institute for the US Department of Homeland Security, National Biodefense Analysis and Countermeasures Center, Frederick, MD, USA
| | - Z. Xu
- Center for Disease Imaging, Radiology, and Imaging Services, National Institutes of Health, Bethesda, MD, USA
| | - J. A. Boydston
- Battelle National Biodefense Institute for the US Department of Homeland Security, National Biodefense Analysis and Countermeasures Center, Frederick, MD, USA
| | - J. Solomon
- Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., NCI Campus at Frederick, Frederick, MD, USA
| | - J. K. Bohannon
- Integrated Research Facility, National Institute of Allergy and Infectious Disease (NIAID), Frederick, MD, USA
| | - J. J. Yeager
- Battelle National Biodefense Institute for the US Department of Homeland Security, National Biodefense Analysis and Countermeasures Center, Frederick, MD, USA
| | - J. R. Taylor
- Battelle National Biodefense Institute for the US Department of Homeland Security, National Biodefense Analysis and Countermeasures Center, Frederick, MD, USA
| | - R. J. Reeder
- Integrated Research Facility, National Institute of Allergy and Infectious Disease (NIAID), Frederick, MD, USA
| | - P. Sayre
- Integrated Research Facility, National Institute of Allergy and Infectious Disease (NIAID), Frederick, MD, USA
| | - J. Seidel
- Integrated Research Facility, National Institute of Allergy and Infectious Disease (NIAID), Frederick, MD, USA
| | - D. J. Mollura
- Center for Disease Imaging, Radiology, and Imaging Services, National Institutes of Health, Bethesda, MD, USA
| | - M. C. Hevey
- Battelle National Biodefense Institute for the US Department of Homeland Security, National Biodefense Analysis and Countermeasures Center, Frederick, MD, USA
| | - P. B. Jahrling
- Integrated Research Facility, National Institute of Allergy and Infectious Disease (NIAID), Frederick, MD, USA
| | - M. G. Lackemeyer
- Integrated Research Facility, National Institute of Allergy and Infectious Disease (NIAID), Frederick, MD, USA
| |
Collapse
|